White et al., "Induction Chemotherapy for Advanced Head and Neck Cancer . . . ," Am. J. Clin. Oncol. (CCT), 15(1) (1992), pp. 45-55. |
S. Lybak et al., "Dose schedule evaluation of metoclopramide . . . ," Anti-Cancer Drugs 2: 375-82 (1991). |
R. J. Nelt et al., "Phamacokinetis of Non-Protein-Bound Platinum Species . . . ," Cancer Treat. Rep. 63: 1515-21 (1979). |
J. Hansson et al., "Cis-Diamminedichloroplatinum (II) Toxicity . . . ," Acta Oncologica 27: 383-92 (1988). |
K. C. Micetich et al., "A Comparative Study of the Cytotoxicity . . . ," Cancer Research 45: 4043-47 (1985). |
L. A. Zwelling et al., "DNA-Protein and DNA Interstrand Cross-Linking . . . ," Cancer Research 39: 365-69 (1979). |
C. A. Perez et al., "Impact of Irradiation Technique and Tumor Extent . . . ," Cancer 50: 1091-99 (1982). |
E. Kjellen et al., "Metoclopramide enhances the effect of cisplatin . . . ," Br. J. Cancer 59: 247-50 (1989). |
E. Kjellen et al., "A therapeutic benefit from combining normobaric carbogen . . . ," Radiotherapy and Oncology 22: 81-91 (1991). |
S. Lybak, Metoclopramide: A representative of a new class of drugs for potentiation of cytotoxicity, University of Lud, Sweden (1991), p. 115. |